During the past decade, Instituto Dermatologico y Cirugia de Piel conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Dermatologico y Cirugia de Piel" #1 sponsor was "DermBiont, Inc." with 3 trials, followed by "Novan, Inc." with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored, "NovaBay Pharmaceuticals, Inc." with 1 trials sponsored and "Promius Pharma, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Dermatologico y Cirugia de Piel" #1 collaborator was "Instituto Dermatologico y Cirugia de Piel" with 1 trials as a collaborator, "International Dermatology Research, Inc." with 1 trials as a collaborator, "Novum Pharmaceutical Research Services" with 1 trials as a collaborator and "ethica Clinical Research Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Dermatologico y Cirugia de Piel" are "Tinea Pedis" (2 trials), "AIDS" (1 trials), "Acne" (1 trials), "Acne Vulgaris" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Instituto Dermatologico y Cirugia de Piel" in a lesser frequency.

Most popular intervention types in "Instituto Dermatologico y Cirugia de Piel" are "Drug" (9 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cohort 1 J. Lividum" (1 trials), "Fluconazole" (1 trials), "J. Lividum" (1 trials), "J. lividum" (1 trials) and "Liarozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Dermatologico y Cirugia de Piel" are 8 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Dermatologico y Cirugia de Piel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Instituto Dermatologico y Cirugia de Piel, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Dermatologico y Cirugia de Piel, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".